Introduction
============

The functional gastrointestinal disorders (FGIDs) are comprised of a group of conditions that are currently defined by the presence of certain symptoms attributable to the gastrointestinal (GI) tract, in the absence of organic causes identifiable by routine investigations.[@b1-jnm-21-83] To harmonize research in this field, a framework known as the Rome Criteria was developed to attempt classification of patients into diagnostic labels based putatively on the sites of the GI tract and the pathophysiological disturbances implicated.[@b2-jnm-21-83]

However, these symptom-based diagnostic criteria, though led to substantial progress in research and care of patients with FGIDs, have limitations as there is lack of uniformity in socio-cultural issues, languages, symptom reporting and spectrum of FGIDs across the world.[@b3-jnm-21-83] Moreover, these criteria and questionnaires were written in English in the first iteration, and subsequently translated into other languages. However, the nuances of some English wording may not be appreciated by non-English speakers and conversely, some regional terms may not have equivalent English word. As the identification and classification of FGIDs are dependent entirely on the ability of patients to describe and of the clinicians and investigators to interpret symptoms, we wonder if these criteria would do well in diagnostic allocation, sub-typing and treatment assignment uniformly throughout the world.[@b4-jnm-21-83]

In epidemiologic, pathophysiologic and therapeutic studies of FGIDs, the Rome Criteria have been applied almost universally. Epidemiological studies from Asia suggest that the prevalence and spectrum of FGIDs may differ in Asia compared to the West.[@b3-jnm-21-83],[@b5-jnm-21-83]--[@b12-jnm-21-83] There is growing interest to evaluate this issue in a more systematic manner in multi-national cross-cultural studies.[@b13-jnm-21-83]--[@b15-jnm-21-83] One of the barriers to such studies relates to the lack of a culturally adapted international questionnaire that has been translated and validated in various Asian languages using standard methods.[@b16-jnm-21-83] As FGIDs are diagnosed by symptoms-based criteria,[@b17-jnm-21-83],[@b18-jnm-21-83] which are subject to psychosocial and socio-cultural influences,[@b7-jnm-21-83],[@b19-jnm-21-83],[@b20-jnm-21-83] it is important that the terminologies used in the questionnaire are culturally adapted, so that the patients can understand their meanings clearly.[@b13-jnm-21-83],[@b14-jnm-21-83],[@b21-jnm-21-83],[@b22-jnm-21-83] Accordingly, we undertook a study with the following aims: (1) to develop a socio-culturally adapted questionnaire based on the Rome III diagnostic questionnaire (R3DQ),[@b23-jnm-21-83] (2) to translate it into various Asian languages according to the Rome Foundation guidelines,[@b24-jnm-21-83] and (3) linguistic validation of the translated questionnaire to demonstrate that the various Asian translations of the Enhanced Asian Rome III questionnaire (EAR3Q) were able to allocate diagnosis according to the Rome III criteria.

Materials and Methods
=====================

The Study Protocol
------------------

This was a 3-phase prospective study involving experts with recent publications on FGIDs from 9 countries, mostly from Asia (2 of which are English-speaking, namely Singapore and USA). The organization of this study is presented in [Figure](#f1-jnm-21-83){ref-type="fig"}. In the third phase of the study, the translated questionnaire has been field tested in a pan-Asian survey. However, in this report, we present the findings from phase 1 and 2 of this study. The findings of the Asian FGID Study will be presented in separate manuscripts.

Phase 1: Development of Enhanced Asian Rome III Questionnaire From Rome III Diagnostic Questionnaire
----------------------------------------------------------------------------------------------------

These experts were tasked to evaluate the translatability of the R3DQ to the languages of their country. Specifically, we sought to identify questions that posed difficulty for patients to understand the nuances pertaining to their English expression. The experts were encouraged to conduct cognitive interviews with their patients to understand how the relevant questions were interpreted.

The working groups were organized according to the way the R3DQ was divided into anatomical sections, ie, esophagus, stomach and intestines, gallbladder or pancreas and rectum or anal canal. The working groups were tasked to examine the adequacy of the questions to describe the Asian person's pattern of symptom reporting for the sections they were assigned. At a round-table meeting, the experts presented their findings. The R3DQ was reviewed question by question. For the questions that were identified to be difficult for an Asian patient to understand, new questions were developed taking account of socio-cultural factors and encompassing the nuances of Asian languages. New questions were also developed for symptoms where it was found that existing questions were inadequate for describing Asian patients' and physicians' clinical encounters. In the new questions we used neutral terms to describe patients' symptom experiences, as much as possible. The new questions will be referred to as Asian adapted questions. To maintain compatibility with the R3DQ and to allow for comparison with earlier studies, we retained all the original questions in their original wording, but positioned the Asian adapted questions directly after each of the original question. The combination of the R3DQ with the Asian adapted questions was named the EAR3Q, which is presented in the [Supplementary Table 1](#SD1){ref-type="supplementary-material"}.

Phase 2: Translation-Validation of Enhanced Asian Rome III Questionnaire Into Various Languages
-----------------------------------------------------------------------------------------------

From January to December 2011, The EAR3Q was translated into the following languages: Chinese, 2 Indian (Hindi and Telugu), Indonesian, Korean, and Thai. These translations were then tested on a prospective sample of patients speaking these languages and suffering from irritable bowel syndrome (IBS), functional dyspepsia (FD) and functional constipation (FC), as well as native healthy subjects (HS). Translation-validation was conducted according to the Rome Foundation guidelines for new language translations.[@b21-jnm-21-83]

### The process of translation of the Enhanced Asian Rome III questionnaire

EAR3Q was translated into each language by 2 independent translators separately ([Asian versions 1a and 1b, Figure](#f1-jnm-21-83){ref-type="fig"}). Subsequently, the 2 versions were reconciled by another expert well-conversant in the respective language to create a final translated questionnaire (Asian version 2), which was back translated into English by another qualified expert well-conversant in both languages. The original and the backward English versions of the questionnaire were assessed for similarity of language and comparability of interpretation, and where necessary, revisions and modifications were made to the Asian version to produce Asian version 3. The final Asian versions 3 in different languages are in [Supplementary Tables 2--7](#SD1){ref-type="supplementary-material"}.

### Validation of the translated questionnaires

After the process of translation as described above, the questionnaires were validated on the HS and patients with IBS, FD, and FC (diagnosed by clinicians using Rome III criteria as in practice setting, by symptoms, negative alarm features[@b17-jnm-21-83],[@b18-jnm-21-83] with exclusion of organic disease with appropriate investigations, which is considered as the gold standard) belonging to respective nations and speaking respective language as their native language. The diagnosis of each group of patients with FGID was made initially by the clinician as he/she would do in his/her clinical practice by interview using the Rome III criteria, and investigating alarm features where these were present. Subsequently, the patients were asked to fill in the translated questionnaire. Each subject was asked to fill in the questionnaire himself/herself. However, in most centres, a research assistant sat with the subject at the time of filling the questionnaire. Exclusion criteria of patients included presence of alarm symptoms, the cause for which had not been verified with appropriate investigations. After a 2--week period, subjects were asked to repeat the questionnaire to check for its reproducibility. Supplemental questions, as detailed in [Supplementary Table 1](#SD1){ref-type="supplementary-material"}, were not included when questionnaire-based diagnoses were compared to the clinical diagnoses. The study protocol was approved by the Ethics Committee of the respective Institutes. Informed consent was obtained from each subject.

### Statistical Methods

The categorical and continuous data are presented as proportion, median and range, respectively. We assessed the validity of the questionnaire by examining its sensitivity to pick-up clinicians' diagnoses (considered as gold standard) at the initial visit. If the questionnaire picked-up the diagnoses made by the clinician, the result was considered true positive and if not, it was considered false negative. For calculation of specificity, the proportion of healthy subjects labelled as healthy was considered. The test-retest reliability analysis involved re-testing subjects after 2 weeks. The agreement between diagnoses made at different time points by the questionnaire was evaluated by kappa statistics. Values for kappa \> 0.810 were considered excellent agreement, between 0.610--0.800 as good agreement and those below \< 0.600 as poor agreement.

Results
=======

Phase 1: Results of Study on Development of Enhanced Asian Rome III Questionnaire From Rome III Diagnostic Questionnaire
------------------------------------------------------------------------------------------------------------------------

While evaluating the translatability of questions in the English version of the R3DQ, to the language of their country, the experts identified difficulty with the questions on globus, dysphagia, odynophagia, anal blockage and digital manoeuvres. These questions together with the reasons for difficulty and the adapted questions that we propose are presented in the [Supplementary Table 8](#SD1){ref-type="supplementary-material"} as R3DQ Q No. 3, 4, 56, and 57.

While examining the adequacy of the original questions for describing the Asian person's pattern of symptom reporting, the experts identified that complaints about excessive gas as well as symptoms associated with gas (belching, fullness and bloating) were highly prevalent. The existing questions in the R3DQ were considered to be insufficient to elucidate the association between these symptoms and gas. It was also brought to attention that the term used to describe constipation in many of Asian languages (Chinese and Korean) was literally translated to mean difficulty in releasing stools. There were insufficient questions in R3DQ to explore the understanding and perception of this Asian concept on the term constipation. The additional questions developed to probe deeper into the characteristics of these symptoms are presented in the [Supplementary Table 8](#SD1){ref-type="supplementary-material"} as R3DQ Q No. 14, 40, 56, 57 and 66.

The experts also reported that fullness and bloating were very common complaints among patients in whom they had made a clinical diagnosis of IBS. In some countries, the experts felt that bloating was more common than abdominal pain. It was further observed that many of these patients reported relief of their fullness or bloating with the passage of either stool or flatus. Therefore, options were added to elucidate the effects of passing stools and of passing flatus to R3DQ Q No. 14 and 66 ([Supplementary Table 8](#SD1){ref-type="supplementary-material"}).

The experts felt the need for a diagrammatic or pictorial representation to enable the interviewer to capture the desired information better in relation to the area related to location of abdominal pain; in R3DQ Q No. 17 and 68, patients were asked if they had experienced pain in the epigastrium or right hypochondrium. The experts observed that their patients had difficulty understanding the descriptions given on these 2 locations. Therefore, in these questions, a diagram of the abdomen divided into the standard nine quadrants was included.

Discrepancy was observed between verbal descriptors and patients' perceptions in relation to stool form. According to Rome or recently proposed Asian criteria,[@b25-jnm-21-83] stool form is important to define constipation rather than frequency. Whereas Rome III criteria define Bristol types 1 or 2 stool forms as constipation, Asian criteria include type 3 stool as well to define constipation.[@b25-jnm-21-83] Therefore, considering the importance of stool form to define constipation, a pictorial diagram of the Bristol stool scale was included to R3DQ Q No. 62 to overcome ambiguity arising from verbal descriptors. We extended this question to incorporate questions that would allow us to encompass patients' perceptions of their bowel habits, of what stool forms constitutes constipation, diarrhoea and a healthy bowel habit.

No change was made to the scoring algorithm; the frequency and severity scales in the RD3Q were retained for all the questions. However, for some of our new questions we added options that seek to relate the timing of symptoms to meals. For example, we considered that the question relating to globus (R3DQ Q No. 3) was ambiguous, as it could be interpreted to refer to dysphagia. Therefore, options were added to define the timing in relation to meals. We also added a scoring that takes into account the size of a meal for the question on post-prandial fullness (R3DQ Q No. 14).

Phase 2: Results of Translation-Validation Study
------------------------------------------------

### The translated questionnaire

The translated questionnaires had high concordance with the original English EAR3Q. [Supplementary Tables 2--7](#SD1){ref-type="supplementary-material"} presents the reconciled version of the questionnaire in different Asian languages used in further validation studies. The understandability of the questionnaire by patients was not systematically investigated by cognitive debriefing. While administering the questionnaire during the validation study, many HS and the patients reported that questions were easily understood. However, most subjects reported that the questionnaire was quite lengthy. Time needed to complete the questionnaire was quite long as per data from 4 centers (median 35 \[range 15--90\] minutes).

### Demographic and clinical variables of the study subjects

[Table 1](#t1-jnm-21-83){ref-type="table"} presents data on demographic and clinical parameters of HS, patients with IBS, FD, and FC included in the validation studies.

### Result of validation of the translated questionnaires

[Table 2](#t2-jnm-21-83){ref-type="table"} presents the data on result of validation studies on translated questionnaires (sensitivity and specificity to pick-up clinical diagnoses and kappa values for test-retest agreement). Sensitivity and specificity of the questionnaires were high (60--100%) to diagnose respective FGIDs (gold standard: clinical diagnoses) in most except Korean (27--67%) and Indonesian (30--60%) languages. Test- retest agreement (kappa) values of the translated questionnaires were variable. The Hindi, Telugu, and Chinese questionnaires had high concordance (kappa value 0.700--1.000) between the initial questionnaire-based diagnosis and that on 14th day. However, concordance for the Korean and Indonesian questionnaires varied between 0.100 and 0.500 and for the Thai questionnaire was 0.800. Diagnostic performance of the Indonesian and Korean questionnaires was particularly low for FC, IBS, and FD ([Table 2](#t2-jnm-21-83){ref-type="table"}). In the Korean cohort, patients who had been categorized by their doctors to have FD showed particularly low concordance (only 3/11, 27%) with the outcome based on the patients' responses to the EAR3Q; 4/11 (36%) were found to qualify IBS-criteria and another 2 (18%) as functional bloating, while 5 (46%) did not fulfil any specific FGID diagnosis. Some of the patients diagnosed as FC failed to meet the criteria on filling the questionnaire. In some languages, such as Hindi and Chinese, the questionnaire often uncovered symptoms of associated disorders such as FD among patients with IBS and FC and IBS among patients with FD both at the initial and at the 2-week follow-up visits ([Table 2](#t2-jnm-21-83){ref-type="table"}).

Discussion
==========

In this study, a group of Asian FGID experts developed a socio-culturally adapted questionnaire (EAR3Q) for evaluating patients with FGIDs in Asia from R3DQ by consensus. Moreover, these experts, who are conversant with the target languages, translated and validated the EAR3Q into Chinese, Hindi-Telugu, Korean, Indonesian, and Thai following the guidelines formulated by the Rome Foundation.[@b21-jnm-21-83],[@b24-jnm-21-83] Culturally adapting the questionnaire has been recommended[@b21-jnm-21-83] to achieve conceptually equivalent meaning and intent of the original instrument. There are cultural contexts and linguistic nuances in Asian languages that have potentially important impact on the interpretation of symptoms relating to the FGIDs.

We found that the nuances of some English wording were not appreciated by non-English speakers, eg, hurt to swallow, food or drinks get stuck after swallowing (stuck where?), and mushy stools. In most of the Asian languages, exact equivalent words are lacking for terms like heartburn and bloating. Moreover, there was overlap in the terms or words used to describe fullness, bloating and distension. For example, the Chinese word "zhang" is used to describe distension, but this word is also used to describe bloating and fullness.

In one study from China, when comparing between patients with FD alone and patients who were classified as FD-IBS overlap based on the Rome III criteria, post-prandial fullness predicted the presence of co-existing IBS.[@b26-jnm-21-83] We suspect that some of these patients might not have experienced fullness, but instead were experiencing bloating, and could have been classified as IBS alone without FD overlap. In another study from Taiwan, about half of the patients initially classified as having FD, were found to have pure IBS, when it was confirmed that the sensations they had reported in the upper abdomen were relieved by defecation.[@b27-jnm-21-83]

In contrast to Western patients with IBS who localize pain more frequently to the lower abdomen, Asian patients often appear to localize their pain more frequently to the upper abdomen.[@b28-jnm-21-83] In some Asian cultures, food and nutrition have traditionally been viewed as an important aspect of health and of illness. For example, "*The Chinese do not draw any distinction between food and medicine*."[@b29-jnm-21-83] It is conceivable that this cultural perspective could influence patients to perceive disturbed functions of the stomach as the origin of their symptoms.

We also observed that many of our patients in whom we make a clinical diagnosis of IBS may fail to fulfil Rome Criteria because they do not complain of pain.[@b4-jnm-21-83] Across the Asian countries, we found that bloating was a dominant complaint among patients with IBS.[@b3-jnm-21-83] It is possible that some of these patients may label their abdominal pain or discomfort as bloating. In a study by Gerson et al,[@b30-jnm-21-83] significant positive correlations between the severity of abdominal pain and bloating were found across 7 countries (USA, Mexico, Canada, England, Italy, Israel, and India); this suggests that IBS subjects in these countries conceptualize pain and bloating as different but related concomitants of gastrointestinal disturbance.

The Rome Criteria indicate that hard stool refers to either Bristol type 1 or 2. However, in a study from South Korea, close to three-quarters of patients with IBS who had verbally reported passing hard stools, failed to meet this criteria.[@b31-jnm-21-83] We found some evidence that point to a relatively shorter colonic transit time among Asians compared with those reported in the West, both for healthy volunteers as well as subjects with constipation.[@b3-jnm-21-83],[@b25-jnm-21-83] To allow the patient's perspectives to be taken into consideration, we introduced a new approach of asking patients what type of stools were passed when they felt they were experiencing constipation, diarrhoea or normal bowel habits. Furthermore, we sought to explore the Asian peoples' concepts of constipation, by extending the questions on anal blockage by asking their perception of the stool characteristics when it was difficult to pass.

In validation study of the translated questionnaires, the diagnostic performance of Chinese, Hindi, and Telugu translations of the EAR3Q was high. Among all the translations, Korean and Indonesian translated EAR3Q often failed to diagnose several specific FGIDs although these questionnaires performed well in categorizing HS as healthy. This might be related to the fact that the physicians made the diagnosis without global evaluation for different subtypes of FGIDs, and therefore, in busy clinic, tended to overlook overlapping FGIDs. Other reasons may be related to recall bias by the patients on symptom duration and limitations of Rome III criteria. Moreover, small sample size in the present study might have over-estimated the frequency of overlap syndromes. In the Korean cohort, patients who had been categorized by their doctors to have FD showed particularly low concordance (only 3/11, 27%) with the outcome based on the patients' responses to the EAR3Q; 4 (36%) were found to qualify as IBS and another 2 (18%) as functional bloating, while 5 (46%) did not fulfil any specific FGID diagnosis. This may reflect the failure of the doctors to enquire about bowel habits in the patients that they had diagnosed as FD, rather than failure of EAR3Q. In fact, this is one of the major diagnostic issue that we encounter in Asia where physicians frequently appear to mis-diagnose IBS as FD.[@b3-jnm-21-83] This scenario is consistent with the observations by Lu et al,[@b27-jnm-21-83] that half of all patients presenting with upper abdominal symptoms who had received an initial diagnosis of FD were found on detailed questioning to have upper abdominal symptoms fulfilling IBS criteria. Similarly in the Indonesian cohort we found that only 40% of patients given a diagnosis of FD by their doctors fulfilled these criteria based on the questionnaire, while 30% achieved criteria for IBS in their questionnaire. Another poor performer was in FC where only 30% of patients who were thought by their doctors to have FC were able to satisfy Rome III criteria based on the questionnaire. One possible explanation is the discrepancy between the patients' perception which places importance to hardness of stool and incomplete evacuation, and the physicians' concept of constipation which emphasizes infrequent bowel movement.[@b32-jnm-21-83] In a study from South Korea it was observed that close to three-quarters of patients who complained of hard stools failed to meet Rome criteria for hard stools.[@b31-jnm-21-83] There are studies from Asia which point to shorter colonic transit times relative to those reported from the West.[@b3-jnm-21-83] Thus, some of the discordance that we observed in our validation study may be due to important and relevant socio-cultural and even physiological differences between the East and the West.

We, for the first time, developed EAR3Q and successfully translated and validated it in several Asian languages. There was a good degree of understandability among the volunteers, a high sensitivity and specificity to diagnose various FGIDs and the test-retest reliability in Hindi-Telugu and Chinese questionnaire; these suggest that these translations were successful. Thai questionnaire also performed reasonably well. However, the Korean and Indonesian questionnaires were not found as valid and may require additional work to improve their test statistics. With the current trend of increasing number of drug trials in non-English speaking areas of world, importance of such translation cannot be over-estimated. The translated questionnaires in various Asian languages will be made available for use by other workers in the field. The busy clinicians may also use these questionnaires in clinical practice for global evaluation of patients with FGIDs, which will help them to particularly recognize the overlapping conditions that may have important bearing on treatment.

A few limitations of the current study are worth mentioning. The questionnaire is expected to work better in younger and more educated people than older and less educated people. The HS included in all the validation studies except in Korea and Thailand were younger than the patients ([Table 1](#t1-jnm-21-83){ref-type="table"}). For less educated people, developing questionnaires with pictorial representations may be more useful. Some of the Asian languages have different dialect and pronunciations. People of rural areas may have somewhat variant understanding of some words than those in urban areas. For test-retest reliability, 2-week interval may be short and even may result in learning effect leading to different result. Small sample size in validation study is another limitation. It is however, under further validation in a large sample of patients with FGIDs in an Asian FGIDs survey, which will be published as separate papers. We believe, though not substantiated by the data, that these limitations are unlikely to be major limitations.

The questionnaire was able to identify overlapping FGIDs quite often that the clinicians had missed. This is not entirely unexpected as firstly, overlap syndromes are common,[@b3-jnm-21-83],[@b6-jnm-21-83],[@b33-jnm-21-83]--[@b36-jnm-21-83] and secondly, physicians in a busy clinic may choose to focus only on the most bothersome symptom. Since overlap between various types of FGIDs is common[@b3-jnm-21-83],[@b6-jnm-21-83],[@b33-jnm-21-83]--[@b36-jnm-21-83] and since this may have therapeutic and prognostic importance,[@b37-jnm-21-83] the use of a diagnostic questionnaire may help busy clinicians to completely evaluate patients with FGIDs.

In conclusion, we have successfully developed a socio-culturally adapted questionnaire and translated it in several major Asian languages (Hindi-Telugu, Chinese, Korean, Indonesian and Thai). We believe that a culturally adapted questionnaire that takes into account the linguistic nuances and socio-cultural perspectives, is an important first step towards describing a true picture of FGID in Asia.
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###### 

Number of Healthy Subjects, Patients With Irritable Bowel Syndrome, Functional Dyspepsia, and Functional Constipation Included in Validation Study and Their Demographic Parameters

  Demographic parameters         Healthy subjects   Irritable bowel syndrome   Functional constipation   Functional dyspepsia
  ------------------------------ ------------------ -------------------------- ------------------------- ----------------------
  Hindi validation study         n = 10             n = 10                     n = 10                    n = 10
    Age (median \[range\], yr)   26 (21--56)        33 (17--53)                45.5 (18--66)             49.5 (26--65)
    Gender (M:F)                 4:6                8:2                        3:7                       7:3
  Telegu validation study        n = 10             n = 11                     n = 6                     n = 8
    Age (median \[range\], yr)   25.5 (23--30)      33.0 (18--62)              42 (24--55)               45.5 (24--63)
    Gender (M:F)                 4:6                11:0                       5:1                       3:5
  Chinese validation study       n = 6              n = 9                      n = 14                    n = 9
    Age (median \[range\], yr)   26.5(24--47)       46(24--65)                 41(20--59)                42(23--65)
    Gender (M:F)                 2:4                3:6                        8:6                       4:5
  Korean validation study        n = 14             n = 9                      n = 11                    n = 6
    Age (median \[range\], yr)   36.5 (24--52)      37 (27--48)                33 (31--65)               38 (21--58)
    Gender (M:F)                 5:9                6:3                        4:7                       0:6
  Indonesian validation study    n = 10             n = 10                     n = 10                    n = 10
    Age (median \[range\], yr)   32.8 (21--62)      46.9 (22--72)              43.1 (26--63)             45.2 (22--67)
    Gender (M:F)                 5:5                7:3                        1:9                       1:9
  Thai validation study          n = 10             n = 10                     n = 10                    n = 10
    Age (median \[range\], yr)   44 (26--66)        45 (24--63)                46.5 (37--65)             53 (14--62)
    Gender (M:F)                 3:7                2:8                        3:7                       1:9
  Total number of subjects       60                 59                         61                        53

###### 

Diagnostic Performance of Translated Versions of Enhanced Asian Rome III Questionnaires

  Clinical diagnostic category                                                                                   Concordance between clinical and questionnaire-based diagnosis on initial visit   Sensitivity   Specificity                                                                                                           Concordance of the questionnaire between initial and 14th day visit   Kappa (EAR3Q-based diagnoses at initial and 2-week follow-up)   
  -------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------- ------------- --------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------- --------------------------------------------------------------- -------
  Hindi                                                                                                          HS (n = 10)                                                                       10            100%                                                                                                                  100%                                                                  10                                                              1.000
  IBS (n = 10)                                                                                                   10                                                                                100%                                                                                                                                10                                                                    1.000                                                           
  7 (70%) had FD symptoms also                                                                                                                                                                                   7 (70%) had FD symptoms also                                                                                                                                                                                                                                
  FC (n = 10)                                                                                                    10                                                                                100%                                                                                                                                10                                                                    1.000                                                           
  9 (90%) had FD symptoms also                                                                                                                                                                                   9 (90%) had FD symptoms also                                                                                                                                                                                                                                
  FD (n = 10)                                                                                                    10                                                                                100%                                                                                                                                10                                                                    1.000                                                           
  6 (60%) had IBS symptoms also                                                                                                                                                                                  4 (40%) had IBS symptoms also                                                                                                                                                                                                                               
  Telugu                                                                                                         HS (n = 10)                                                                       10            100%                                                                                                                  100%                                                                  10                                                              1.000
  IBS (n = 11)                                                                                                   11                                                                                100%                                                                                                                                11                                                                    1.000                                                           
  3 (27%) had FD symptoms also                                                                                                                                                                                   2 (18%) had FD symptoms also                                                                                                                                                                                                                                
  FC (n = 6)                                                                                                     6                                                                                 100%                                                                                                                                6                                                                     1.000                                                           
  1 (17%) had FD symptoms also                                                                                                                                                                                   1 (17%) had FD symptoms also                                                                                                                                                                                                                                
  FD (n = 8)                                                                                                     8                                                                                 100%                                                                                                                                8                                                                     1.000                                                           
  Chinese                                                                                                        HS (n = 6)                                                                        6             100%                                                                                                                  100%                                                                  6                                                               1.000
  IBS (n = 9)                                                                                                    9                                                                                 100%                                                                                                                                7 (77.8%)                                                             0.700                                                           
  FC (n = 9)                                                                                                     9                                                                                 100%                                                                                                                                8                                                                     0.900                                                           
  1 (11%) had FD symptoms also                                                                                                                                                                                                                                                                                                                                                                                                                                               
  FD (n = 14)                                                                                                    14                                                                                100%                                                                                                                                10                                                                    0.700                                                           
  5 (35.7%) had FC symptoms also                                                                                                                                                                                 2 (20%) had FC symptoms also                                                                                                                                                                                                                                
                                                                                                                                                                                                                 1 (10%) had IBS symptoms also                                                                                                                                                                                                                               
  Korean                                                                                                         HS (n = 14)                                                                       13 (93%)      93%                                                                                                                   93%                                                                   14                                                              1.000
  IBS (n = 9)                                                                                                    5                                                                                 55.5%                                                                                                                               4                                                                     0.400                                                           
  1 (11%) had FD and 1 (11%) had functional bloating also and 4 did not fulfil criteria for any specific FGIDs                                                                                                   1 had FD and 4 did not fulfil criteria for any specific FGIDs                                                                                                                                                                                               
  FC (n = 6)                                                                                                     4                                                                                 67%                                                                                                                                 3                                                                     0.500                                                           
  2 (33%) had functional bloating also, 1 IBS and 1 did not fulfil criteria for any specific FGIDs                                                                                                               1 (17%) had FD also and 3 had IBS                                                                                                                                                                                                                           
  FD (n = 11)                                                                                                    3                                                                                 27%                                                                                                                                 3                                                                     0.300                                                           
  3 (27%) had IBS also, 2 functional bloating, 1 IBS only and 5 did not fulfil criteria for any specific FGIDs                                                                                                   3 (27%) had IBS also and 2 had functional bloating, 2 had IBS, and 4 did not fulfil criteria for any specific FGIDs                                                                                                                                         
  Indonesian                                                                                                     HS (n = 10)                                                                       9             90%                                                                                                                   90%                                                                   9                                                               0.900
  IBS (n = 10)                                                                                                   6                                                                                 60%                                                                                                                                 3                                                                     0.300                                                           
  3 had FD symptoms also                                                                                                                                                                                         2 had FD symptoms also                                                                                                                                                                                                                                      
  FC (n = 10)                                                                                                    3                                                                                 30%                                                                                                                                 1                                                                     0.100                                                           
  2 had FD symptoms also                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  FD (n = 10)                                                                                                    4                                                                                 40%                                                                                                                                 4                                                                     0.400                                                           
  3 had IBS symptoms also                                                                                                                                                                                        1 had IBS                                                                                                                                                                                                                                                   
  Thai                                                                                                           HS (n = 10)                                                                       9             90%                                                                                                                   90%                                                                   8                                                               0.800
  IBS (n = 10)                                                                                                   6                                                                                 60%                                                                                                                                 8                                                                     0.800                                                           
  FC (n = 10)                                                                                                    6                                                                                 60%                                                                                                                                 8                                                                     0.800                                                           
  1 had IBS and 1 FD had symptoms also                                                                                                                                                                                                                                                                                                                                                                                                                                       
  FD (n = 10)                                                                                                    8                                                                                 80%                                                                                                                                 8                                                                     0.800                                                           
  1 (10%) had functional bloating also                                                                                                                                                                           1 (10%) had functional bloating also                                                                                                                                                                                                                        

EAR3Q, Enhanced Asian Rome III questionnaires; HS, healthy subject; IBS, irritable bowel syndrome; FC, functional constipation; FD, functional dyspepsia.
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